Novavax reported $1.6B in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adma Biologics ADMA:US $ 0.39B 0.03B
Agenus AGEN:US $ 0.52B 0.11B
AstraZeneca AZN:LN 16734.4B 1035.33B
Astrazeneca AZN:US 203.74B 2.44B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Dynavax Technologies DVAX:US $ 1.59B 0.24B
Genocea Biosciences GNCA:US $ 0.07B 0.01B
Geron GERN:US $ 0.58B 0.14B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Mannkind MNKD:US $ 0.96B 0.03B
Merk MRK:US $ 230.55B 23.1B
Minerva Neurosciences NERV:US $ 0.02B 0.02B
Moderna Inc MRNA:US $ 56.82B 12.6B
Novartis NVS:US 203.52B 10.87B
Novavax NVAX:US $ 4.02B 1.6B
Pain Therapeutics PTIE:US $ 1.13B 0.36B
Peregrine Pharmaceuticals PPHM:US $ 0.94B 0.31B
Pfizer PFE:US $ 294.18B 1.79B
Sanofi SAN:FP 121.89B 4.99B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Tg Therapeutics TGTX:US $ 0.61B 0.74B